West Pharma (WST) Tops Q3 EPS by 4c; Boosts FY13 Outlook; Announces Stock Split

August 1, 2013 7:14 AM

West Pharmaceutical Services, Inc. (NYSE: WST) reported Q3 EPS of $0.86, $0.04 better than the analyst estimate of $0.82. Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found